Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ZARS Vitamin D3
- Development stage
- Unknown
- Lead developer
- Apotex
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
ZARS Vitamin D3 is an oral nutritional supplement developed by ZARS Pharma, containing cholecalciferol (Vitamin D3). It is indicated for the treatment of Vitamin D deficiency and provides supportive care for bone health and immune function. As a precursor to the active form of Vitamin D, cholecalciferol is metabolized to calcitriol, which binds to the Vitamin D receptor (VDR) to regulate calcium and phosphate homeostasis, promote intestinal calcium absorption, and modulate immune system activity. The product is marketed in Pakistan as part of a consumer health portfolio, with a high-potency branded version known as DELTAZARS.
- Brand names
- DELTAZARS
- Other names
- cholecalciferolVitamin D3
02
Targets
RXRA (Retinoid X receptor alpha)RBD (SARS-CoV-2 spike receptor-binding domain)TMPRSS2 (Transmembrane protease serine 2)VDR (Vitamin D receptor)ACE2 (Angiotensin-converting enzyme 2)
Beyond the preview
Go deeper on ZARS Vitamin D3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ZARS Vitamin D3.